Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-30Clinical Trial Update: Study to Evaluate the Safety and Efficacy of PEER Interactive to Inform Medication Prescription for Subjects With a Primary Diagnosis of Depression [Phase 2, Phase 3]
A clinical trial update for PEER Interactive evaluating safety and efficacy in depression has been suspended.
-
CLINICAL_TRIALS trial_result · 2020-07-30Clinical Trial Update: The Antidepressant Advisor Study [Phase 2]
Phase 2 clinical trial update for an antidepressant in Major Depressive Disorder.
-
CLINICAL_TRIALS trial_result · 2020-07-28Clinical Trial Update: Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD) [Phase 3]
Phase 3 trial of rapastinel as monotherapy for major depressive disorder was terminated; results posted in 2020.
-
FDA approval · 2020-07-28FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (Contract Pharmacal Corp.)
FDA approved an original application for doxepin hydrochloride, a generic product from Contract Pharmacal Corp., with labeling for major dep…
-
FDA approval · 2020-07-24FDA Approved: DOXEPIN — Original Application (Strides Pharma Science Limited)
FDA approved an original application for doxepin hydrochloride (generic doxepin) by Strides Pharma Science Limited, expanding the availabili…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-24Clinical Trial Update: A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) [Phase 4]
Phase 4 clinical trial investigating brexpiprazole in combination with ketamine for treatment-resistant depression has completed with result…
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Feasibility of a Yoga- and Mindfulness-Based Intervention for Resident Physicians [NA]
A completed clinical trial evaluating the feasibility of a yoga- and mindfulness-based intervention for resident physicians to address burno…
-
FDA approval · 2020-07-21FDA Approved: PAROXETINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Paroxetine hydrochloride from Apotex Corp., enabling continued marketing of a generic product.
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD) [Phase 3]
Phase 3 trial of adjunctive or monotherapy rapastinel for major depressive disorder was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Deep Brain Stimulation for Treatment Resistant Depression [NA]
Clinical trial update on deep brain stimulation for treatment-resistant depression (major depressive disorder). Results were posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Depression Therapy to Improve Cardiovascular Risk in HIV [NA]
Clinical trial on Depression Therapy aimed at improving cardiovascular risk in people with HIV has completed and posted results.
-
FDA approval · 2020-07-10FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for a generic Bupropion Hydrochloride Extended-Release (XL) product.
-
CLINICAL_TRIALS trial_result · 2020-07-10Clinical Trial Update: Mindfulness-Based Recovery in Veterans [NA]
Clinical trial update for Mindfulness-Based Recovery in Veterans with substance abuse and depression; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects [Phase 2]
Phase 2 trial update evaluating how sirolimus influences the antidepressant effects of ketamine; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Enhanced Medical Rehabilitation in Older Adults [NA]
Completed clinical trial on enhanced medical rehabilitation in older adults; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-02Clinical Trial Update: Ketamine and Nitroprusside for Depression [Phase 2]
Phase 2 trial update investigating ketamine and nitroprusside for depression has completed, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-01Clinical Trial Update: Depression, Obesity and Inflammatory Markers [NA]
Clinical trial update from NCT02765100 featuring bipolar disorder, depression, and obesity with completed status and posted results.
-
FDA approval · 2020-06-30FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Supplemental Application (ScieGen Pharmaceuticals,Inc.)
FDA approved a supplemental application to authorize the marketing of Bupropion Hydrochloride (XL) from ScieGen Pharmaceuticals, the extende…
-
FDA approval · 2020-06-30FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Bupropion Hydrochloride from Rising Pharma Holdings, Inc., for a generic product under an AN…
-
FDA approval · 2020-06-30FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Supplemental Application (Exelan Pharmaceuticals Inc.)
FDA approved a supplemental application for bupropion hydrochloride extended-release (XL) from Exelan Pharmaceuticals Inc., enabling continu…
-
CLINICAL_TRIALS trial_result · 2020-06-22Clinical Trial Update: Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder [Phase 3]
Phase 3 long-term safety study of rapastinel as adjunctive therapy in adults with major depressive disorder has completed; results posted in…
-
CLINICAL_TRIALS trial_result · 2020-06-22Clinical Trial Update: Treatment of Adolescent Suicide Attempters (TASA) [Phase 2, Phase 3]
Phase 2/3 clinical trial update for treatment of adolescent suicide attempters.
-
CLINICAL_TRIALS trial_result · 2020-06-19Clinical Trial Update: Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults [Phase 1, Phase 2]
A completed phase 1/2 trial comparing Magnetic Seizure Therapy to Electroconvulsive Therapy for depression in older adults; results posted i…
-
CLINICAL_TRIALS trial_result · 2020-06-18Clinical Trial Update: DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole [Phase 4]
Phase 4 clinical trial update for a digital medicine study in adults using aripiprazole for schizophrenia, major depressive disorder, or bip…
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients [Phase 1, Phase 2]
A clinical trial exploring metformin as an adjunct to antidepressants in major depressive disorder has completed Phase 1 and Phase 2.